Intravenous iron products differ on infusion times and adverse reactions

Intravenous iron treatment has a shorter infusion time and fewer adverse adverse events when ferric carboxymaltose is used compared to iron polymaltose, a study in women at a Victorian maternity service has shown. Clinicians at the Royal Women’s Hospital in Melbourne made the observation after they switched from iron polymaltose (Ferrum H injection) to ferric carboxymaltose (Ferinject) ...

Already a member?

Login to keep reading.

© 2021 the limbic